NextGen Knowledge Center

Cancer Registry Reporting

During a patient encounter, the cancer registry functions enable you to document the diagnosis, evaluation, and treatment of active cancer for cancer registry reporting purposes.

When the encounter is concluded and locked, the application generates a cancer report that is sent to the national cancer registry through an HL7 interface. By capturing these data elements, providers can meet the 2015 Quality Reporting certification objectives.

To satisfy cancer registry reporting guidelines, you must record the following types of information.

Patient demographic information
In addition to the general patient data, the national cancer registry requires documentation of specific demographic data points, including race, ethnicity, occupation, and nation of birth.
General cancer diagnosis and treatment data
This includes data such as onset date, cancer notes, radiation notes, and problem description.
Cancer staging data
You can enter cancer staging data on the Onc Treatment Summary template or in any other template that has cancer staging grids. You can also perform related functions, such as entering notes pertinent to cancer staging and recording cancer-related medications.

NextGen® Adaptive Content Engine is designed specifically for the national registry. It supports reporting for the national cancer registry and all state cancer registries. If your state registry has requirements not addressed inNextGen® Adaptive Content Engine, contact NextGen Healthcare.

To stage cancer types accurately and meet the guidelines set by the American Joint Committee on Cancer (AJCC), NextGen® Adaptive Content Engine supports the following.

  • Ability to free text cancer cases.
  • Risk score for Gestational Trophoblastic Tumor stage group.
  • Heritable Trait when documenting Retinoblastoma.
  • Mitotic rates associated with the Gastrointestinal Stromal Tumor cancer type.
  • SNOMED coding for TNM values and stages.
  • Reference template for grade group and PSA range table when documenting prostate cancer.
  • French Federation of Comprehensive Cancer Centers (FNLCC) Histologic grades and scores applicable to the Soft Tissue Sarcoma cancer types.
  • International Federation of Obstetricians and Gynecologists (FIGO) stage system applicable for cancer types of female reproductive organs.